BEI Medical Plans Year 2000 PMA Filing For Endometrial HydroThermAblator
This article was originally published in The Gray Sheet
BEI Medical Systems is on target to complete Phase III studies of its Hydro ThermAblator system for thermal endometrial ablation in the first quarter.
You may also be interested in...
BEI Medical Systems' Hydro ThermAblator (HTA) system for endometrial ablation will provide a new option for gynecologists in the treatment of menorrhagia when it becomes available, likely in early 2001.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.